Pharmafile Logo

Lucid Group has four programmes shortlisted for PMEA 2019

Lucid is celebrating four of their programmes being shortlisted in four categories at this year’s PMEAs

- PMLiVE

Lucid’s talent for partnering with its clients to create magical healthcare communications is evident as they celebrate four of their programmes making the PMEA 2019 finals.

Jan Steele, Lucid Group COO and Co-founder commented, “2019 has been a transformative year for Lucid Group. We have gone through two acquisitions, allowing us to increase capability and reach. With all this change, it is a testament to our team’s dedication and passion that they continue to deliver outstanding work for our clients. I do not doubt that as we move into 2020 we will continue this incredible momentum with our work helping to transform more lives than ever before.”

PMEA recognises the achievements of responsible customer-centric business practices that provide patients with meaningful outcomes. The winners will be announced on Wednesday 27 November 2019 at the Royal Lancaster London.

More details about the shortlisted programmes can be found below:

Category: Excellence in Healthcare Professional Education and Support Programmes:   
CLEAR HORIZONS: A new era of psoriasis care
INSPIRE: Improving outcomes in paediatric cardiology

Category: Excellence in Capability Development
Global Medical Affairs as CATALYSTs for change

Category: Excellence in Innovation
DermDialogue: Bringing innovation to MSL‐led education

Excellence in Rare Diseases and Orphan Drugs
INSPIRE: Improving outcomes in paediatric cardiology

This content was provided by Lucid Group Communications Limited

Company Details

 Latest Content from  Lucid Group Communications Limited 

The Lucid Winter Summit 2016

Lucid Group put their skates on this year to celebrate an outstanding year’s performance at the Lucid Winter Summit at Somerset House, London.  Lucid Group enter their tenth year of...

2017: Medical education that improves value and outcomes for patients

In December’s Issue of PME, two of Lucid’s senior management team – Shula Sarner and Tanya Goodyear – consider how medical education will evolve in 2017.   They discuss industry...

Lucid Group kick off their Winter Festival

The start of December not only signalled the official calendar countdown to Christmas, but also marked the official launch of the Lucid Winter Festival, which culminates in the Winter Summit...

Leading Edge expands their senior medical writing team

Leading Edge, part of the Lucid Group specialising in strategic health communications and medical education, has bolstered its senior medical writing team with the new appointment of Jennifer (Jennie) Badger. Jennie...

Lucid win PMEA Support Agency of the Year 2016

Last night the Lancaster London Hotel hosted the annual PMEA awards. These awards recognise and commend companies and programmes demonstrating excellence, best practice and innovation in improving patient outcomes on...

Lucid strengthens its creative services department

There’s no slowing down for Lucid Group as it completes its first decade of trading early next year. In parallel with the recent appointments in its senior leadership team, Lucid...

Changing behaviour: putting theory into practice

In the November issue of PME, Madeleine Tye (senior account manager at Lucid Group) discusses Lucid’s approach to medical education. Lucid employs the outcomes of research into behavioural science in...

Tajinder’s #LucidLife

Medical writers are like gold dust, so when we find talented writers with great experience,we offer a tailor-made package.Are you a world-class medical writer?Do you like the look of Tajinder’s...

Fiona’s #LucidLife

Meet Fiona, a medical writer.She told us what she wanted, and we did the rest.We believe that medical writers are like gold dust; so when we find talent, we do...

Lucid Group: What medical communications means to us

Katherine Duxbury, Scientific Director at Lucid, explains what medical communications means to Lucid: What we do, how we do it and what makes us different.